ipriflavone has been researched along with Pain in 6 studies
ipriflavone : A member of the class of isoflavones that is isoflavone in which the hydrogen at position 7 is replaced by an isopropoxy group. A synthetic isoflavone, it was formerly used for the treatment of osteoporosis, although a randomised controlled study failed to show any benefit. It is still used to prevent osteoporosis in post-menopausal women.
Pain: An unpleasant sensation induced by noxious stimuli which are detected by NERVE ENDINGS of NOCICEPTIVE NEURONS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Twenty patients with post-menopausal osteoporosis were randomly divided into two groups of ten patients and treated under double-blind conditions with ipriflavone (Osteofix) or placebo." | 9.06 | Metabolic and clinical effects of ipriflavone in established post-menopausal osteoporosis. ( Agnusdei, D; Bigazzi, S; Cepollaro, C; Gennari, C; Montagnani, M; Nardi, P; Zacchei, F, 1989) |
| "Twenty patients with post-menopausal osteoporosis were randomly divided into two groups of ten patients and treated under double-blind conditions with ipriflavone (Osteofix) or placebo." | 5.06 | Metabolic and clinical effects of ipriflavone in established post-menopausal osteoporosis. ( Agnusdei, D; Bigazzi, S; Cepollaro, C; Gennari, C; Montagnani, M; Nardi, P; Zacchei, F, 1989) |
| "Ipriflavone was administered as oral capsules dosed at 200 mg, 3 times a day for 12 months." | 2.67 | New perspectives in the treatment of postmenopausal osteoporosis: ipriflavone. ( Caserta, D; Moscarini, M; Palermo, P; Patacchiola, F; Spacca, G; Valenti, M, 1994) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (33.33) | 18.7374 |
| 1990's | 4 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Moscarini, M | 1 |
| Patacchiola, F | 1 |
| Spacca, G | 1 |
| Palermo, P | 1 |
| Caserta, D | 1 |
| Valenti, M | 1 |
| Zsuzsanna, B | 1 |
| Szántó, F | 1 |
| Agnusdei, D | 2 |
| Camporeale, A | 1 |
| Gonnelli, S | 1 |
| Gennari, C | 2 |
| Baroni, MC | 1 |
| Passeri, M | 1 |
| Zacchei, F | 1 |
| Bigazzi, S | 1 |
| Cepollaro, C | 1 |
| Nardi, P | 1 |
| Montagnani, M | 1 |
| Kuzuna, S | 1 |
| Doi, T | 1 |
| Morimoto, S | 1 |
| Tsukuda, R | 1 |
| Shino, A | 1 |
| Maki, Y | 1 |
1 review available for ipriflavone and Pain
| Article | Year |
|---|---|
[Place of ipriflavone in the therapy of osteoporosis].
Topics: Controlled Clinical Trials as Topic; Estrogen Replacement Therapy; Female; Humans; Isoflavones; Oste | 1995 |
3 trials available for ipriflavone and Pain
| Article | Year |
|---|---|
New perspectives in the treatment of postmenopausal osteoporosis: ipriflavone.
Topics: Administration, Oral; Aged; Bone Density; Female; Humans; Isoflavones; Middle Aged; Osteoporosis, Po | 1994 |
Short-term treatment of Paget's disease of bone with ipriflavone.
Topics: Administration, Oral; Aged; Alkaline Phosphatase; Bone and Bones; Creatinine; Double-Blind Method; F | 1992 |
Metabolic and clinical effects of ipriflavone in established post-menopausal osteoporosis.
Topics: Bone and Bones; Clinical Trials as Topic; Double-Blind Method; Female; Flavonoids; Humans; Isoflavon | 1989 |
2 other studies available for ipriflavone and Pain
| Article | Year |
|---|---|
[Experience with ipriflavone therapy in postmenopausal osteoporosis].
Topics: Aged; Analgesics; Female; Humans; Isoflavones; Middle Aged; Osteoporosis, Postmenopausal; Pain | 1997 |
[Effects of ipriflavone (TC-80, an anti-osteoporotic drug) on acute and chronic pain].
Topics: Administration, Oral; Animals; Arthritis; Estrone; Flavonoids; Isoflavones; Joints; Male; Mice; Ovar | 1986 |